Acerca de
Oniria Therapeutics, a company from the precision oncology field, wants to solve cancer persistence by bringing to the market the first-in-class drug ONR-001, for the treatment of solid and liquid aggressive tumors who are not responding to treatment, setting the base for new rational drug combinations or standing alone treatments.
Preguntas adicionales
Organization
Biotech - Therapeutics and Diagnostics